Prosecution Insights
Last updated: August 16, 2026

Tempus Al Inc.

8 pending office actions • 4 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (88%)
0
Medium (0%)
1
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (62%)
Double-patenting only1 (12%)
Multi-statute (no §101)2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
1
Information Tech
12% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
12% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAILEY, STEVEN WILLIAM 2 32.0% +20.2%
HRANEK, KAREN AMANDA 1 35.6% +40.7%
NGUYEN, TRI T 1 66.8% +15.6%
LIN, JERRY 1 72.3% +15.0%
KRIANGCHAIVECH, KETTIP 1 20.0% +30.6%
ANDERSON-FEARS, KEENAN NEIL 1 9.1% +45.0%
NEGIN, RUSSELL SCOTT 1 55.8% +34.1%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17527646 ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING KRIANGCHAIVECH, KETTIP 29d
16789288 TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS BAILEY, STEVEN WILLIAM 55d
18513153 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL HRANEK, KAREN AMANDA
18478889 METHODS AND SYSTEMS FOR DISEASE PHENOTYPING USING MULTIMODAL EHR DATA AND WEAK SUPERVISION NGUYEN, TRI T
17527657 METHODS AND SYSTEMS FOR REFINING COPY NUMBER VARIATION IN A LIQUID BIOPSY ASSAY ANDERSON-FEARS, KEENAN NEIL
17323982 SYSTEMS AND METHODS FOR USING SEQUENCING DATA FOR PATHOGEN DETECTION NEGIN, RUSSELL SCOTT
16945588 METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY BAILEY, STEVEN WILLIAM

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17527646 ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING KRIANGCHAIVECH, KETTIP 29d
16789288 TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS BAILEY, STEVEN WILLIAM 55d
18513153 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL HRANEK, KAREN AMANDA
18478889 METHODS AND SYSTEMS FOR DISEASE PHENOTYPING USING MULTIMODAL EHR DATA AND WEAK SUPERVISION NGUYEN, TRI T
18150194 ARTIFICIAL IMMUNOHISTOCHEMICAL IMAGE SYSTEMS AND METHODS LIN, JERRY
17527657 METHODS AND SYSTEMS FOR REFINING COPY NUMBER VARIATION IN A LIQUID BIOPSY ASSAY ANDERSON-FEARS, KEENAN NEIL
17323982 SYSTEMS AND METHODS FOR USING SEQUENCING DATA FOR PATHOGEN DETECTION NEGIN, RUSSELL SCOTT
16945588 METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY BAILEY, STEVEN WILLIAM

Top Art Units

Art UnitApps
1687 3
1686 2
3684 1
2128 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18513153 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL HRANEK, KAREN AMANDA 3684 §103§112 Non-Final OA Pending Nov 17, 2023
18478889 METHODS AND SYSTEMS FOR DISEASE PHENOTYPING USING MULTIMODAL EHR DATA AND WEAK SUPERVISION NGUYEN, TRI T 2128 §101§103§112 Non-Final OA Pending Sep 29, 2023
18150194 ARTIFICIAL IMMUNOHISTOCHEMICAL IMAGE SYSTEMS AND METHODS LIN, JERRY DP Non-Final OA Pending Jan 04, 2023
17527646 ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING KRIANGCHAIVECH, KETTIP 1686 §101§112 Non-Final OA 29d Pending Nov 16, 2021
17527657 METHODS AND SYSTEMS FOR REFINING COPY NUMBER VARIATION IN A LIQUID BIOPSY ASSAY ANDERSON-FEARS, KEENAN NEIL 1687 §101DP Final Rejection Pending Nov 16, 2021
17323982 SYSTEMS AND METHODS FOR USING SEQUENCING DATA FOR PATHOGEN DETECTION NEGIN, RUSSELL SCOTT 1686 §103§112 Final Rejection Pending May 18, 2021
16945588 METHODS AND SYSTEMS FOR DETECTING MICROSATELLITE INSTABILITY OF A CANCER IN A LIQUID BIOPSY ASSAY BAILEY, STEVEN WILLIAM 1687 §101§112 Final Rejection Pending Jul 31, 2020
16789288 TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS BAILEY, STEVEN WILLIAM 1687 §101§112 Non-Final OA 55d Pending Feb 12, 2020

Managing Tempus Al Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month